  The value of preclinical diffusion MRI (dMRI) is substantial. While dMRI
enables in vivo non-invasive characterization of tissue, ex vivo dMRI is
increasingly being used to probe tissue microstructure and brain connectivity.
Ex vivo dMRI has several experimental advantages including higher
signal-to-noise ratio and spatial resolution compared to in vivo studies, and
more advanced diffusion contrasts for improved microstructure and connectivity
characterization. Another major advantage is direct comparison with
histological data as a crucial methodological validation. However, there are a
number of considerations that must be made when performing ex vivo experiments.
The steps from tissue preparation, image acquisition and processing, and
interpretation of results are complex, with many decisions that not only differ
dramatically from in vivo imaging, but ultimately affect what questions can be
answered using the data. This work represents 'Part 2' of a series of
recommendations and considerations for preclinical dMRI, where we focus on best
practices for dMRI of ex vivo tissue. We first describe the value that ex vivo
imaging adds to the field of dMRI, followed by general considerations and
foundational knowledge that must be considered when designing experiments. We
then give guidelines for ex vivo protocols, including tissue preparation,
imaging sequences and data processing including pre-processing, model-fitting,
and tractography. Finally, we provide an online resource which lists publicly
available ex vivo dMRI datasets and dedicated software packages. In each
section, we attempt to provide guidelines and recommendations, but also
highlight areas for which no guidelines exist, and where future work should
lie. An overarching goal herein is to enhance the rigor and reproducibility of
ex vivo dMRI acquisitions and analyses, and thereby advance biomedical
knowledge.
